GlassScriptPhysician profile
Melissa Benavides
NPI 1356360101
$4,632.56
in general payments reported to CMS, 2019-2025
39 companies · $883 in 2025
The $883 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,093 · 2022: $978 · 2023: $929 · 2024: $750 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $830.29 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $701.24 | 2021-2025 | |
| Amgen INC. | $476.15 | 2021-2025 | Evenity, Repatha, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.61 | 2021-2025 | Jardiance |
| Astellas Pharma US INC | $269.91 | 2021-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $185.09 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Sanofi-Aventis U.S. LLC | $177.46 | 2021-2024 | |
| Glaxosmithkline, LLC. | $156.09 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $136.37 | 2021-2025 | |
| Dexcom, INC. | $130.73 | 2022-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $127.95 | 2022-2024 | |
| Exact Sciences Corporation | $103.18 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $88.86 | 2021-2023 | Xarelto |
| Abbott Laboratories | $84.07 | 2021-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $82.12 | 2021-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Benavides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.